Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-02

Clinical Trial Update: Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) [Phase 2]

View source ↗

Summary

Phase 2 trial update for SDP-4 in dry eye disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SDP-4

Snippet

Sponsor: Silk Technologies, Ltd. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2022-09-02